Bridget Martell - Nov 16, 2021 Form 4 Insider Report for Aligos Therapeutics, Inc. (ALGS)

Role
Director
Signature
/s/ Lucinda Y. Quan, as attorney-in fact for Bridget Martell
Stock symbol
ALGS
Transactions as of
Nov 16, 2021
Transactions value $
$0
Form type
4
Date filed
11/18/2021, 03:38 PM
Next filing
Jun 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALGS Stock Option (Right to Buy) Award $0 +30K $0.00 30K Nov 16, 2021 Common Stock 30K $16.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the total number of shares vest in thirty-six (36) successive and equal monthly installments measured from November 16, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.